Comparison between Nigra & zolpidem in menopausal women with sleep disorder

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201306192576N7

Enrollment

Registered

2013-07-16

Start date

2013-07-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopause. Menopausal and female climacteric states

Interventions

Intervention 1: Tablet Nigra/1 tablet at bed time 1/day for 8 weeks . Intervention 2: Tablet Zolpidem 5mg/day for 8 weeks at bed time.

Treatment - Drugs

Tablet Nigra/1 tablet at bed time 1/day for 8 weeks .

Tablet Zolpidem 5mg/day for 8 weeks at bed time.

Eligibility

Sex/Gender

Female

Age

45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: menopausal women with sleep disorders. Exclusion criteria: women who use benzodiazepines or they have history of depression

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

Measure	Time frame
Sleep disorder. Timepoint: after 8,12weeks. Method of measurement: Pittsburgh's questionnaire.	—

Primary

Measure	Time frame
Sleep disorders. Timepoint: Before intervention, 8 and 12 weeks after intervention. Method of measurement: Pittsburgh's questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

fatedavari@yahoo.com+98 21 8853 2663

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026